HER2 and response to paclitaxel in node-positive breast cancer.
- Citation:
- N Engl J Med vol 357 (15) 1496-506
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- CA092461, CA31946, CA33601
- Corr. Author:
- Authors:
- Daniel F Hayes Ann D Thor Lynn G Dressler Donald Weaver Susan Edgerton David Cowan Gloria Broadwater Lori J Goldstein Silvana Martino James N Ingle I Craig Henderson Larry Norton Eric P Winer Clifford A Hudis Matthew J Ellis Donald A Berry
- Networks:
- Study
- CALGB-9344
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adult, Antineoplastic Agents, Phytogenic, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Chemotherapy, Adjuvant, Cyclophosphamide, Doxorubicin, Female, Follow-Up Studies, Humans, Middle Aged, Paclitaxel, Receptor, ErbB-2, Receptors, Estrogen, Treatment Outcome